CD4 and COVID-19: The combination of low CD4 and NK cells resulted in a 9.5-fold higher risk of adverse outcome, independently of age and sex.<h4>Conclusions</h4>Specific immune profiles, particularly reductions in CD4+ and NK cells, are strong predictors of mortality or ICU admission in hospitalized COVID-19 patients.